Race-associated molecular changes in gynecologic malignancies.

Area of Science:

• Genomic medicine
• Cancer genomics
• Health disparities research

Background:

• Significant disparities in cancer morbidity and mortality exist among different racial groups.
• African-American women with gynecologic malignancies experience well-established adverse outcomes.
• Social determinants of health may influence environmental interactions with tumor epigenomes and genomes.

Purpose of the Study:

• To identify specific genomic alterations in gynecologic tumors from African-American patients.
• To explore potential links between social health disparities and tumor genomic/epigenomic changes.
• To discover novel therapeutic targets by comparing genomic data across racial groups.

Main Methods:

• Utilized The Cancer Genetic Ancestry Atlas for ancestry-based analysis of The Cancer Genome Atlas data.
• Conducted large-scale comparative analyses of methylation, transcript, and microRNA expression.
• Focused on gynecologic malignancies in women of African American and European American racial groups.

Main Results:

• Identified novel, discrete genomic changes in gynecologic malignancies.
• Revealed differences in methylation, transcript, and microRNA expression between racial groups.
• Provided data supporting the potential mediation of environmental interactions by social health disparities.

Conclusions:

• Novel genomic alterations in gynecologic cancers are identified between African-American and European-American women.
• The findings suggest a framework for investigating the role of social disparities in cancer development.
• This research highlights potential new therapeutic targets for gynecologic malignancies in underrepresented populations.